Publications by authors named "E E Graf"

Background: Amyloid PET imaging is an established diagnostic tool for Alzheimer's disease, but its successful integration into clinical practice requires a comprehensive understanding of its impact on patients and the healthcare system. In 2022, the coverage with evidence development (CED) ENABLE study has been approved by the German Federal Joint Committee (trial registration: DRKS00030839). The study is scheduled to start in early 2024.

View Article and Find Full Text PDF

Background: Amyloid PET imaging is an established diagnostic tool for Alzheimer's disease, but its successful integration into clinical practice requires a comprehensive understanding of its impact on patients and the healthcare system. In 2022, the coverage with evidence development (CED) ENABLE study has been approved by the German Federal Joint Committee (trial registration: DRKS00030839). The study is scheduled to start in early 2024.

View Article and Find Full Text PDF

Metagenomic sequencing of plasma has been advertised by Karius, Inc. as a way to diagnose a variety of infectious syndromes. Due to the lack of robust evidence of clinical utility, our laboratory began actively stewarding Karius testing.

View Article and Find Full Text PDF
Article Synopsis
  • The text discusses the rapid development of Large Language Models (LLMs) like OpenAI's GPT and their increasing importance in fields such as science and medicine, yet highlights the need for evaluating their quality and effectiveness in statistical applications.
  • The project's objective is to explore the utility and satisfaction of LLMs in statistical consulting by creating and assessing a training module, while identifying strengths and areas for improvement.
  • The study employs a multimodal approach, incorporating both qualitative and quantitative methods across four parts to gather insights on using LLMs in consulting, evaluating training effectiveness, and understanding staff experiences and attitudes at the Medical Center and University of Freiburg.
View Article and Find Full Text PDF

Objective: Multiplex polymerase chain reaction (PCR) panels for stool testing may be used to diagnose , which can circumvent more appropriate targeted testing, resulting in treatment of incidentally detected colonization. We sought to reduce diagnosis via a gastrointestinal pathogen panel (GIPP).

Design: Quasi-experimental, pre/post, retrospective cohort study from January 1, 2022, to January 31, 2024.

View Article and Find Full Text PDF